ÂÜÀòÂÒÂ×

Tomasz Kula is a Junior Fellow in the Harvard Society of Fellows. During his Ph.D. work at Harvard in the lab of Steve Elledge, he focused on developing new technologies to profile the immune system. He worked on a high-throughput platform called VirScan to map the targets of anti-viral antibodies. He also developed the T-Scan platform for high-throughput mapping of T cell epitopes and co-founded TScan Therapeutics, which is applying the platform to develop novel cancer immunotherapies. He has been the recipient of multiple fellowships, including the NSF GRFP and the Harvard Biogen Innovation Grant. Tomasz graduated Magna Cum Laude with Highest Honors in Molecular and Cellular Biology from Harvard College.